Lianghe Lu
Overview
Explore the profile of Lianghe Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He B, Deng M, Li S, Mei J, Lu L, Zuo Z, et al.
Int J Med Sci
. 2025 Mar;
22(6):1415-1424.
PMID: 40084258
Transarterial chemoembolization (TACE) is an optional treatment for hepatocellular carcinoma (HCC) patients with macrovascular invasion (MVI) and without extrahepatic metastasis (EHM). As a recently emerging approach, the efficacy of hepatic...
2.
Li S, Mei J, Zhao R, Zhou J, Wang Q, Lu L, et al.
Front Immunol
. 2024 Nov;
15:1491857.
PMID: 39507533
Background: A combination of hepatic arterial infusion chemotherapy (HAIC), lenvatinib, and immune checkpoint inhibitors (ICIs) yields a high tumor response rate and survival benefit in unresectable hepatocellular carcinoma (uHCC). However,...
3.
Jin X, Lv Y, Bie F, Duan J, Ma C, Dai M, et al.
Cell Death Differ
. 2024 Oct;
32(3):466-479.
PMID: 39472692
Oxaliplatin-based therapeutics is a widely used treatment approach for hepatocellular carcinoma (HCC) patients; however, drug resistance poses a significant clinical challenge. Epigenetic modifications have been implicated in the development of...
4.
Ma L, Zhang C, Wen Y, Xing K, Li S, Geng Z, et al.
Int J Surg
. 2024 Jul;
111(1):872-883.
PMID: 39051653
Background: Patients with microvascular invasion (MVI)-positive hepatocellular carcinoma (HCC) have shown promising results with adjuvant hepatic arterial infusion chemotherapy (HAIC) with FOLFOX after curative resection. The authors aim to develop...
5.
Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, et al.
J Hepatocell Carcinoma
. 2024 Apr;
11:665-678.
PMID: 38596593
Background: Microvascular invasion (MVI) is a significant pathological feature in hepatocellular carcinoma (HCC), adjuvant hepatic arterial infusion chemotherapy (a-HAIC) and adjuvant transcatheter arterial chemoembolization (a-TACE), are commonly used for HCC...
6.
Lin W, Lu L, Zheng R, Yuan S, Li S, Ling Y, et al.
J Cancer Res Clin Oncol
. 2023 Oct;
149(19):17231-17239.
PMID: 37801135
Purpose: Vessels encapsulating tumor clusters (VETC) is a novel vascular pattern structurally and functionally distinct from microvascular invasion (MVI) in hepatocellular carcinoma (HCC). This study aims to explore the prognostic...
7.
Chen J, Lu L, Qu C, A G, Deng F, Cai M, et al.
Front Med (Lausanne)
. 2022 Oct;
9:981001.
PMID: 36203764
Immunocheckpoint inhibitors have shown significant efficacy in the treatment of hepatocellular carcinoma (HCC), but there are individual differences. The aim of this study was to explore body mass index (BMI)...
8.
Guan R, Lin W, Zou J, Mei J, Wen Y, Lu L, et al.
Cancer Control
. 2022 May;
29:10732748221102820.
PMID: 35609265
Background: Vessels that encapsulate tumor cluster (VETC) is associated with poor prognosis in hepatocellular carcinoma (HCC). Vessels that encapsulate tumor cluster estimation before initial treatment is helpful for clinical doctors....
9.
Zhang Y, Lu L, He Z, Xu Z, Xiang Z, Nie R, et al.
Front Immunol
. 2022 Feb;
13:808101.
PMID: 35185894
Background: Serum C-reactive protein (CRP) is a biomarker of an acute inflammatory response and has been successfully used as a prognostic predictor for several malignancies. However, the clinicopathological significance of...
10.
Mei J, Lin W, Li S, Tang Y, Ye Z, Lu L, et al.
J Exp Clin Cancer Res
. 2022 Jan;
41(1):5.
PMID: 34980201
Background: Long non-coding RNAs (lncRNA) have an essential role in progression and chemoresistance of hepatocellular carcinoma (HCC). In-depth study of specific regulatory mechanisms is of great value in providing potential...